Inmate at San Quentin Prison Tests Positive for Possible Hantavirus
A 38-year-old inmate at San Quentin State Prison in California has contracted a possible case of hantavirus, confirmed by prison authorities on Wednesday. Hantavirus is typically transmitted through contact with contaminated rodent droppings or urine rather than person-to-person, and the inmate is reportedly in stable condition with no other cases identified. The case is significant given hantavirus's 30-40 percent mortality rate and the vulnerability of enclosed institutional settings to disease outbreaks.
San Quentin Rehabilitation Center confirmed that a 38-year-old male inmate has contracted a possible case of hantavirus, with the situation first reported on Monday. Prison officials stated they do not believe the virus was transmitted person-to-person and have not implemented quarantine measures. The inmate is in stable condition, though it remains unclear whether he is being treated at the prison's medical facilities or in his cell. No other potential hantavirus cases have been identified among the facility's 3,000+ inmates. Hantavirus Pulmonary Syndrome is rare but serious, carrying a 30-40 percent mortality rate with no available antiviral treatment. The virus typically spreads through inhalation of contaminated particles from rodent feces or urine, though a rare variant can spread between humans with significant exposure to bodily fluids.
What different sources said
- SFGATECenter
Potential case of rare and deadly hantavirus investigated at Bay Area prison
- ABC7 Bay AreaCenter
San Quentin Rehabilitation Center confirms 38-year-old male inmate contracted possible case of hantavirus
- The IndependentLeft
Prisoner at San Quentin may have hantavirus, authorities say
Related
CAR T-cell therapy puts lupus into remission in pioneering NHS trial
Five lupus patients in England have achieved remission after receiving CAR T-cell therapy, a genetically modified immune treatment, in an early NHS trial at University College London Hospitals. The therapy works by engineering patients' own T cells to destroy malfunctioning B cells, effectively resetting the immune system, and patients have remained well for over 18 months without lupus medication. If confirmed in larger studies, this could represent a potential cure for lupus and may be applicable to other autoimmune diseases like multiple sclerosis and rheumatoid arthritis.
UK to Offer Meningitis B Vaccine to Million Young People Following Outbreak
The UK government has announced a one-off vaccination programme offering two doses of the meningitis B vaccine to approximately one million teenagers in their final school year and young people under 25 starting university, beginning in late July 2026. The decision follows an unprecedented outbreak in Kent and clusters in Dorset and Berkshire that resulted in three deaths, with all cases covered by the Bexero vaccine. The programme aims to protect those at highest risk during university entry, when increased social mixing and shared accommodation elevate transmission risk.
NHS Investigation Finds Gender Care Failures at Brighton GP Clinic, 78 Children Prescribed Medication Inappropriately
An NHS safety investigation found that a Brighton GP practice (WellBN) inappropriately prescribed gender-related medications to 78 children under 18 between February 2023 and December 2025, including some under age 13, often without proper face-to-face appointments or necessary medical oversight. The clinic lacked qualified clinicians and specialist support, failed to conduct required blood tests, and provided treatment that fell "far short of what could be considered safe or appropriate." NHS England has suspended prescriptions to children at the clinic and referred clinicians to medical regulators, highlighting systemic failures in a service created to address long waiting times for specialist gender care.